Horio S, Nagare T, Ishida Y, Moritoki H
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, University of Tokushima, Japan.
J Pharmacol Exp Ther. 1998 Jul;286(1):221-7.
We investigated which of the major actions of local anesthetics (i.e., inhibition of phospholipase A2, interaction with Ca++ channels or blockade of receptor) was responsible for the inhibition of acetylcholine-induced desensitization in guinea pig ileal longitudinal muscle. Desensitization was inhibited by amine local anesthetics and related compounds in the order of potency quinacrine > chloroquine > tetracaine > procaine. Potent phospholipase A2 inhibitors, manoalide (1 microM) and p-bromophenacyl bromide (5 microM) had no effect on desensitization. The rank order of interaction of local anesthetics with Ca++ channels did not agree with the potency order of inhibition of desensitization. These data indicated that local anesthetics did not inhibit desensitization through their inhibition of phospholipase A2 or their interaction with Ca++ channels. Quinacrine, chloroquine, tetracaine and procaine inhibited [3H]N-methylscopolamine binding to solubilized membrane with pKi values of 7.03 +/- 0.10, 6.59 +/- 0.02, 5.40 +/- 0.10 and 5.03 +/- 0.04 and reduced receptor occupancy by agonist from 99.0% (without inhibitor) to 96.8%, 95.1%, 89.4% and 49.8%, respectively, under the conditions where each drug induced half-maximum inhibition of desensitization, indicating that they (except for procaine) did not effectively block muscarinic receptors. However, the combined dose-ratio test showed that some of these drugs (quinacrine and chloroquine) interacted noncompetitively at muscarinic receptors. Therefore, these drugs could have bound to an allosteric site on the receptor, modified agonist-receptor interaction and thus inhibited the pathway specific to the desensitization process.
我们研究了局部麻醉药的主要作用(即抑制磷脂酶A2、与Ca++通道相互作用或阻断受体)中,哪一种是抑制豚鼠回肠纵行肌中乙酰胆碱诱导的脱敏作用的原因。胺类局部麻醉药及相关化合物按效力顺序(奎纳克林>氯喹>丁卡因>普鲁卡因)抑制脱敏作用。强效磷脂酶A2抑制剂, manoalide(1微摩尔)和对溴苯甲酰溴(5微摩尔)对脱敏作用无影响。局部麻醉药与Ca++通道相互作用的顺序与抑制脱敏作用的效力顺序不一致。这些数据表明,局部麻醉药不是通过抑制磷脂酶A2或与Ca++通道相互作用来抑制脱敏作用的。奎纳克林、氯喹、丁卡因和普鲁卡因抑制[3H]N-甲基东莨菪碱与可溶性膜的结合,其pKi值分别为7.03±0.10、6.59±0.02、5.40±0.10和5.03±0.04,并且在每种药物诱导脱敏作用半数最大抑制的条件下,将激动剂的受体占有率分别从99.0%(无抑制剂)降低到96.8%、95.1%、89.4%和49.8%,表明它们(除普鲁卡因外)不能有效阻断毒蕈碱受体。然而,联合剂量-比试验表明,其中一些药物(奎纳克林和氯喹)在毒蕈碱受体上存在非竞争性相互作用。因此,这些药物可能与受体上的变构位点结合,改变了激动剂-受体相互作用,从而抑制了脱敏过程特有的途径。